Please assess the completion status of the following clinical trial:

Trial Title: Intravenous Erythromycin Before Endoscopy in Patients With Variceal Bleeding: A Randomized, Double-Blind Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients with liver cirrhosis or stigmata of chronic liver disease presenting with hematemesis and or melena within previous 12 hours with~* Age \>18 years~* Informed consent~* Hemodynamically stable patient at the time of endoscopy after resuscitation.~Exclusion Criteria:~* Known allergy to erythromycin~* Prior gastric lavage on admission~* Current use of antiarrhythmic drugs~* Prior gastric surgery~* Previous history of cardiac arrhythmias~* Concomitant use of antihistaminic drugs with possible drug interactions with erythromycin~* Prior use of other prokinetic agents~* Pregnancy or lactation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Erythromycin (Type: ACTIVE_COMPARATOR): The patients in erythromycin group received intravenous bolus infusion of 125 mg of erythromycin lactobionate in 50 ml of normal saline
- Placebo Group endoscopic therapy (Type: NO_INTERVENTION): Endoscopic therapy of variceal bleeding.

Based on this trial design, predict the completion outcome and termination type (if applicable).